These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
897 related items for PubMed ID: 1690318
41. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors. Siena S, Bregni M, Bonsi L, Sklenar I, Bagnara GP, Bonadonna G, Gianni AM. Exp Hematol; 1993 Nov; 21(12):1583-90. PubMed ID: 7691640 [Abstract] [Full Text] [Related]
42. Mast cell growth factor (c-kit ligand) restores growth of multipotent progenitors in myelodysplastic syndrome. Glinsmann-Gibson B, Spier C, Baier M, Taetle R, Broudy VC, List AF. Leukemia; 1994 May; 8(5):827-32. PubMed ID: 7514248 [Abstract] [Full Text] [Related]
43. Action of granulopoiesis-stimulating cytokines rhG-CSF, rhGM-CSF, and rmGM-CSF on murine haematopoietic progenitor cells for granulocytes and macrophages (GM-CFC). Hofer M, Vacek A, Weiterová L. Physiol Res; 2005 May; 54(2):207-13. PubMed ID: 15544422 [Abstract] [Full Text] [Related]
45. The use of haemopoietic growth factors in the treatment of myelodysplastic syndromes. Greenberg PL, Negrin R, Nagler A. Cancer Surv; 1990 Nov; 9(1):199-212. PubMed ID: 2276114 [Abstract] [Full Text] [Related]
47. Kinetics of hematopoiesis in bone marrow cultures from patients with chronic myeloid leukemia: effect of recombinant cytokines in dexter-type long-term cultures. Luna-Bautista F, Sánchez-Valle E, Ayala-Sánchez M, Morales-Polanco M, Meillon-García L, Benítez-Bribiesca L, Mayani H. Hematology; 2003 Jun; 8(3):155-63. PubMed ID: 12745649 [Abstract] [Full Text] [Related]
48. Enrichment of CD34 (My10)-positive myeloid and erythroid progenitors from human marrow and their growth in cultures supplemented with recombinant human granulocyte-macrophage colony-stimulating factor. Baines P, Mayani H, Bains M, Fisher J, Hoy T, Jacobs A. Exp Hematol; 1988 Oct; 16(9):785-9. PubMed ID: 2458955 [Abstract] [Full Text] [Related]
50. Dissociation of the proliferation and differentiation stimuli of granulocyte colony-stimulating factor (G-CSF). Irvine AE, Berney JJ, Francis GE. Leukemia; 1990 Mar; 4(3):203-9. PubMed ID: 1690319 [Abstract] [Full Text] [Related]
51. Cytogenetic effects on cells derived from patients with myelodysplastic syndromes during treatment with hemopoietic growth factors. Verhoef G, Van den Berghe H, Boogaerts M. Leukemia; 1992 Aug; 6(8):766-9. PubMed ID: 1640727 [Abstract] [Full Text] [Related]
53. A comparison of treatment of canine cyclic hematopoiesis with recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF), G-CSF interleukin-3, and canine G-CSF. Hammond WP, Boone TC, Donahue RE, Souza LM, Dale DC. Blood; 1990 Aug 01; 76(3):523-32. PubMed ID: 1696146 [Abstract] [Full Text] [Related]
54. Granulocyte-monocyte and Granulocyte-Colony Stimulating Factors in Myelodysplastic Syndromes. Nagler A, Greenberg PL. Leuk Lymphoma; 1991 Aug 01; 5(4):219-30. PubMed ID: 27467843 [Abstract] [Full Text] [Related]
55. Stem cell factor improvement of proliferation and maintenance of hemopoietic progenitors in myelodysplastic syndromes. Piacibello W, Sanavio F, Bresso P, Severino A, Carlesso N, Pregno P, Stacchini A, Morelli S, Fubini L, Gallo E. Leukemia; 1994 Feb 01; 8(2):250-7. PubMed ID: 7508532 [Abstract] [Full Text] [Related]
56. Hematologic and cytogenetic findings in myelodysplastic syndromes treated with recombinant human granulocyte colony-stimulating factor. Ohyashiki K, Ohyashiki JH, Toyama K, Takaku F. Jpn J Cancer Res; 1989 Sep 01; 80(9):848-54. PubMed ID: 2480943 [Abstract] [Full Text] [Related]
57. Effects of recombinant human granulocyte colony-stimulating factor (CSF), human granulocyte macrophage-CSF, and gibbon interleukin-3 on hematopoiesis in human long-term bone marrow culture. Coutinho LH, Will A, Radford J, Schiró R, Testa NG, Dexter TM. Blood; 1990 Jun 01; 75(11):2118-29. PubMed ID: 1693295 [Abstract] [Full Text] [Related]
58. Recombinant human IL-3 and G-CSF act synergistically in stimulating the growth of acute myeloid leukemia cells. Pébusque MJ, Faÿ C, Lafage M, Sempéré C, Saeland S, Caux C, Mannoni P. Leukemia; 1989 Mar 01; 3(3):200-5. PubMed ID: 2465464 [Abstract] [Full Text] [Related]
59. Responses of hemopoietic precursors to 13-cis retinoic acid and 1,25 dihydroxyvitamin D3 in the myelodysplastic syndromes. Swanson G, Picozzi V, Morgan R, Hecht F, Greenberg P. Blood; 1986 Apr 01; 67(4):1154-61. PubMed ID: 3513868 [Abstract] [Full Text] [Related]
60. Priming with recombinant human hematopoietic cytokines before bone marrow harvest expands in vivo and enhances ex vivo recovery of myeloid progenitors in short-term liquid cultures. Johnsen HE, Jensen L, Gaarsdal E, Hansen PB, Ersbøll J, Hansen NE. Exp Hematol; 1994 Jan 01; 22(1):80-6. PubMed ID: 7506675 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]